Glucophage XR tablets

Glucophage is one of the most widely recognized brand names for metformin hydrochloride, a primary medication used in the management of type 2 diabetes. Developed to help control blood sugar levels, the XR (Extended Release) version featured in the image is designed to release the medication slowly into the bloodstream, reducing gastrointestinal side effects common with immediate-release versions.

Originally developed by researchers in France, the brand has grown into a global standard for diabetes care. Due to its essential nature and high demand, Glucophage is manufactured in various pharmaceutical-grade facilities across the globe, including significant production sites in France, Germany, and through regional licensed manufacturers to serve international markets. The brand is a core part of the Merck KGaA portfolio, representing decades of clinical expertise in metabolic health.